Cargando…
Point-of-care testing of coagulation in patients treated with edoxaban
Edoxaban, alongside other direct oral anticoagulants (DOAC), is increasingly used for prevention of thromboembolism, including stroke. Despite DOAC therapy, however, annual stroke rate in patients with atrial fibrillation remains 1–2%. Rapid exclusion of relevant anticoagulation is necessary to guid...
Autores principales: | Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Hörber, Sebastian, Ebner, Matthias, Sonnleitner, Matthias, Spencer, Charlotte, Bombach, Paula, Stefanou, Maria-Ioanna, Kuhn, Joachim, Mengel, Annerose, Ziemann, Ulf, Poli, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515947/ https://www.ncbi.nlm.nih.gov/pubmed/32436010 http://dx.doi.org/10.1007/s11239-020-02143-2 |
Ejemplares similares
-
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
por: Härtig, Florian, et al.
Publicado: (2021) -
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
por: Ebner, Matthias, et al.
Publicado: (2017) -
Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran
por: Härtig, Florian, et al.
Publicado: (2021) -
Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
por: Ebner, Matthias, et al.
Publicado: (2018) -
No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke
por: Laichinger, Kornelia, et al.
Publicado: (2023)